A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
Clinical trial NCT03695185 · COMPLETED
Trial details
- NCT number
- NCT03695185
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2021-04-05
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.